Table 3.

Effect of HDL subfractions (A—in mmol/L; B—in %) on the estimated cardiovascular risk by Systematic Coronary Risk Evaluation and Framingham Risk Scores.

	Systematic Coronary Risk Evaluation	Framingham Risk Scores
	High-risk algorithm	CHD	CVD in general
A
HDL-1	− 11.26*	− 28.37*	− 53.98*
HDL-2	− 6.27*	− 13.43*	− 24.99*
HDL-3	− 5.95*	− 12.99*	− 23.85*
HDL-4	− 4.84	− 12.76*	− 23.23*
HDL-5	− 8.50	− 20.06*	− 39.80*
HDL-6	− 5.10	− 9.93*	− 19.9*
HDL-7	− 8.85	− 12.46	− 25.98
HDL-8	− 8.61	− 4.43	− 14.83
HDL-9	− 6.17	11.85	10.57
HDL-10	0.52	7.31	7.93
HDL-L	− 2.65*	− 5.94*	− 10.94*
HDL-I	− 1.88	− 4.32*	− 8.32*
HDL-S	− 0.81	2.48	1.84
B
HDL-1	− 0.13	− 0.40*	− 0.71*
HDL-2	− 0.08	− 0.24*	− 0.41*
HDL-3	− 0.10	− 0.26*	− 0.42*
HDL-4	− 0.10	− 0.29*	− 0.45
HDL-5	0.03	− 0.18	− 0.39
HDL-6	0.04	0.18	0.33
HDL-7	0.09	0.37	0.68
HDL-8	0.13	0.54*	0.92*
HDL-9	0.17	0.74*	1.20*
HDL-10	0.07	0.18*	0.29*
HDL-L	− 0.05	− 0.12*	− 0.20*
HDL-I	0.01	0.02	0.06
HDL-S	0.04	0.13*	0.20*

HDL-L, large HDL (from HDL-1 to 3); HDL-I, intermediate HDL (from HDL-4 to 7); HDL-S, small HDL (from HDL-8 to 10); CVD, cardiovascular diseases; CHD: coronary heart disease.

*Significant results after test correction (p < 0.004).